24 Oct 2023
Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.
4 Oct 2023
Genomics plc has made it into the Newsweek list of the UK's 100 Most Loved Workplaces 2023. The list is based on feedback from companies' employees and the rankings encompass a company's commitment to equality, diversity and inclusion, its dedication to employee growth and development and its ability to adapt to the needs of its workforce.
25 Nov 2022
Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.
Genomics plc announces successful world-first pilot using improved genomic risk assessment in cardiovascular disease prevention in the NHS
7 Nov 2022
Genomics plc has reported significant, positive results from the world’s first pilot investigating the use of genomic polygenic risk score testing to support the prevention of cardiovascular disease (CVD) in NHS clinical practice, at the American Heart Association Scientific Sessions today.
Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
10 Oct 2022
Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.